Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma.

Biochem Biophys Res Commun

Institute of Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, PR China.

Published: May 2007

Jagged1 is one of the ligands of Notch signaling pathway, which controls cellular proliferation and differentiation, and also plays important roles in various malignant tumors. However, the expression of Jagged1 in hepatocellular carcinoma (HCC) has not been elucidated, nor whether it is associated with hepatitis B virus X protein (HBx). In this study, we found that Jagged1 was highly expressed in 79.2% (42/53) of HCC tissues compared with adjacent nontumor liver (P <0.05), and its expression was found to be closely related with HBx (rs=0.522, P <0.001) in HCC tissues. Our in vitro study also showed that alteration of HBx expression in HCC cell lines led to a consistent change of Jagged1. Moreover, Jagged1 was found to co-localize and directly interact with HBx in HCC tissues and HBx expressed HCC cell lines. Our results reveal that Jagged1, which is regulated by HBx, may contribute to the development of HCC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.02.130DOI Listing

Publication Analysis

Top Keywords

expression jagged1
8
hepatitis virus
8
virus protein
8
hepatocellular carcinoma
8
jagged1 association
4
association hepatitis
4
protein hepatocellular
4
carcinoma jagged1
4
jagged1 ligands
4
ligands notch
4

Similar Publications

To investigate the role of silent information regulator 6 (SIRT6) in regulating podocyte injury in diabetic nephropathy (DN) through autophagy mediated by Notch signaling pathway. A blank control group (group A), a diabetic nephropathy group (group B), and a Sirt6 intervention group (group C) were established. The group A cells were human normal glomerular podocyte cell lines (HGPCs) without any treatment.

View Article and Find Full Text PDF

Ductular reaction (DR) is the hallmark of cholestatic diseases manifested in the proliferation of bile ductules lined by biliary epithelial cells (BECs). It is commonly associated with an increased risk of fibrosis and liver failure. The receptor for advanced glycation end products (RAGE) was identified as a critical mediator of DR during chronic injury.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effects of sinomenine hydrochloride (SH) on colitis induced by DSS in mice, focusing on the Notch signaling pathway.
  • Mice were divided into four groups and assessed for disease activity, mucosal injury, and histopathological changes, revealing that SH significantly alleviated colitis symptoms and reduced inflammation markers.
  • Results indicated that SH treatment lowered the expression of key proteins in the Notch signaling pathway and reduced pro-inflammatory cytokines, suggesting that its therapeutic effect is linked to inhibiting Notch pathway overactivation.
View Article and Find Full Text PDF

Truncated recombinant Jagged1 fused with human IgG1 Fc activates Notch target genes in human periodontal ligament cells.

Arch Oral Biol

November 2024

Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Electronic address:

Objective: Jagged1, a Notch ligand, is essential for osteogenic differentiation in human periodontal ligament cells (hPDLs) by interacting with Notch2 to induce osteogenic markers, alkaline phosphatase activity, and mineral deposition. However, its large size hampers absorption and distribution of biomaterials. This study aimed to identify the critical region of Jagged1 necessary for its interaction with Notch2 to create a truncated version that retains osteogenic activity but with improved delivery characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed GINS1 expression in LUAD tissues compared to healthy controls using various techniques, including bioinformatics, immunohistochemistry, and qRT-PCR, and manipulated GINS1 levels in cancer cell lines to assess its effects on cell proliferation, migration, and invasion.
  • * Initial results indicate variations in GINS1 expression between LUAD patients and healthy controls, and ongoing experiments aim to uncover the underlying molecular mechanisms, potentially identifying new therapeutic targets for LUAD treatment
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!